Navigation Links
EPA Recognizes Fort Wayne Community Schools for Reducing Diesel Emissions From Its School Buses
Date:4/21/2008

CHICAGO, April 21 /PRNewswire-USNewswire/ --- U.S. Environmental Protection Agency Region 5 Acting Air and Radiation Division Director Cheryl Newton this morning recognized the Fort Wayne Community School District, Fort Wayne, Ind., for its work using a $50,000 EPA Clean School Bus grant to reduce harmful diesel emissions from its school bus fleet. The event was held at Elmhurst High School, 3829 Sandpoint Road.

"EPA is working with the Fort Wayne Community Schools to upgrade buses and use cleaner fuels so children can breathe cleaner air and live healthier lives," Newton said. "Breathing diesel exhaust is not good for anyone, especially children."

EPA awarded the grant in late 2006, and FWCS installed diesel oxidation catalysts on 30 buses. Part of the grant was used to buy biodiesel fuel that was shared with the Southwest Allen County Schools. The two districts have been using biodiesel in 372 buses as a result of the grant.

"FWCS is well deserving of recognition," said Fort Wayne Mayor Tom Henry. "They have taken a very important step toward protection of the health of our children and improving the quality of the air that we all breathe. Our community is moving toward a higher recognition of the importance of making choices that will ensure the sort of world we want our children to enjoy."

"We are proud to do our part to ensure we all have cleaner air to breathe," FWCS Superintendent Dr. Wendy Robinson said. "We take our responsibility of being good stewards of the environment seriously. Having clean air is critical for everyone, but especially those children with asthma or other breathing difficulties."

The grant is part of EPA's Clean School Bus USA program. The goal of the program is to reduce children's exposure to diesel exhaust and the amount of air pollution created by diesel school buses. School buses are the safest way for children to get to school. However, pollution from diesel vehicles has health im
'/>"/>

SOURCE U.S. Environmental Protection Agency Region 5
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BlueCross Recognizes Baptist Womens Hospital
2. TriWest Recognizes Contributions of TRICARE Docs to Military Community on Doctors Day
3. Accident Fund Recognizes Clark Construction Co. for 2 Million Hours without a Lost-Time Injury
4. HHS Deputy Secretary Recognizes Grand Rapids Leaders for Improving Quality and Value in Health Care
5. IOF recognizes ESCEO European guidance for osteoporosis diagnosis and management
6. Pezcoller Foundation-AACR International Award for Cancer Research recognizes Axel Ullrich
7. Defense Logistics Agency Recognizes Ehmke Manufacturing Company
8. Award recognizes 2 decades of research that led to the adoption of risk adjustment tools
9. HHS Secretary Recognizes Products of HITSP Standards Work
10. Brain Area Recognizes Familiar Sounds
11. Angel Flight West Recognizes New Mexico Pilots and Receives Grant to Improve Access to Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Steven Mosher,...I), says that America has,a hidden problem of sex ...feminists refuse to address., In PRI,s latest You...,East and South Asian countries, of sex-selective ...actice has already claimed the lives of over 100,m...
(Date:7/24/2008)...July 24 /PRNewswire/ -- A new alliance of animal,l...roblems -- obesity -- in,pets and pet owners., Am...ne third of us are,obese, including 9 million chil...ok like us -- mirror us with similar health issues...partnership that includes,Harvard Medical Center, ...
(Date:7/24/2008)... CosmetaLife clinical trial results could lead ...cost-effective treatment for deep lines and wrinkl...inn. (PRWEB) July 24, 2008 -- Gel-Del Technologie...company announced that it has concluded clinical t...at company officials say holds potential to be a m...
(Date:7/24/2008)...RNewswire-FirstCall/ --, Key Highlights, Misys p...ns and is now,raising targets for the next phase o...) of GBP492m up 6%, bringing Group operating profi...xecuting on its strategy and entering,into the nex...m for growth., To view the Multimedia News Releas...
Breaking Medicine News(10 mins):Health News:PRI: Pro-Life Leader Blames Feminist Groups for Slaughter of Girls 2Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4
...use it or lose it' advice when it comes keeping th...al stimulation can protect the brain from Alzheime... Disease Centre in the US now reveal new evidence ...ious Orders Study, involving the cognitive health ...
...with delirium run a much higher risk of death than...d there's a need for research to identify what cha... interventions that can be made after discharge to...covered 361 patients aged 65 or older, of whom 243...
... using new technology which helps prevent stroke. ...l stroke involves looking, by ultrasound, at any b...ain.// Researchers at Texas University in the US ...ice, based upon a technique called Power Doppler I...
...udies that one of the substance-propolis, a resino...e development of tooth decay. Researchers at the U...// considerably reduces dental plaque formation. P...ase (Gtf) enzymes, enzymes that synthesize glucans...
Other Medicine News:
(Date:7/23/2008)...Dendreon Corporation,(Nasdaq: DNDN ) today announ...g Committee (IDMC) to review in October 2008 the i...e Company,s Phase 3 IMPACT (IMmunotherapy,for Pros...B) clinical trial,of PROVENGE(R) (sipuleucel-T). P...llular immunotherapy for the treatment of advanced...
(Date:7/22/2008)...t Initiative bring MJFF,s,current active industry ...09, NEW YORK, July 22 /PRNewswire-USNewswire/ -- ...ormative treatments and a cure for Parkinson,s,dis...s Research has awarded,$2.7 million in total fundi... granted under MJFF,s Therapeutics Development Ini...
(Date:7/22/2008)...e to Patients of Passing a Follow-...ly 22 /- Insmed Inc. (Nasda... biopharmaceuticals, today,announced that Geoffrey...ngressional briefing on Friday, July 25th, 2008 to...approval pathway for follow-on,biologics (FOB) and...
(Date:7/22/2008)...re-FirstCall/ -- NicOx S.A.,(Euronext Paris: COX) ...enrollment of 417 osteoarthritis (OA) patients wit...logy studies in the United States, in line with,pr...igned to assess the,blood pressure profile of napr...using the Ambulatory Blood Pressure Monitoring (AB...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 1Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 2Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 3Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 4Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 5Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 6Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 7Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 8Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 9Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 10Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 11Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 12Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 13Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 14Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 15Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 16Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 17Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 18Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 19Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 20Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 21Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 22Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 23Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 24Boston Scientific Announces Results for Third Quarter Ended September 30 2007 1366 25AMA 3A NY Attorney General Actions Will Protect Patient Choice of Physicians 4124 1Massive reanalysis of genome data solves case of the lethal genes 1363 1Massive reanalysis of genome data solves case of the lethal genes 1363 2Breast Cancer Survivors and Their Supporters Sing to Live 4121 1Breast Cancer Survivors and Their Supporters Sing to Live 4121 2
... for New Aggrastat Study in American Heart Journal... Inc. (TSX:MPH;,Amex:MCU), a cardiovascular focuse... the two-year, follow-up results from the,STRATEGY...luting,Stent Versus Abciximab and Bare Metal Stent...hed in the July edition of the Journal,of the Amer...
...LD, Conn., July 11, 2007 /PRNewswire/ -- Phase 3 r...hat oral dabigatran,etexilate once daily, administ...o enoxaparin, also administered for an average of ...) and all-cause,mortality after total hip replacem...ding associated with dabigatran etexilate was,simi...
Other Medicine Technology:Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 2Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 3Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 4Positive Aggrastat Results Featured in the Journal of the American,College of Cardiology 5Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5
The GENESIS II* Total Knee System will define the state of knee implants.
Cruciate Retaining, Posterior Stabilized and Constrained Components.
StelKast's Proven knee system is a long term, quality solution based on a clinically proven design. Available in both posterior stabilized and anatomically correct cruciate retaining configurations.
The Balanced Knee System provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results.
Medicine Products: